Basilea Pharmaceutica AG
Basilea Pharmaceutica AG (BPMUF) Stock Overview
Explore Basilea Pharmaceutica AG’s financial performance, market position, analyst ratings, and future outlook.
Key Financials
Key Financials
Market Cap
752.8M
P/E Ratio
-961.39
EPS (TTM)
$7.31
ROE
-0.01%
BPMUF Stock Analysis & Investment Overview
Our comprehensive AI-powered analysis of Basilea Pharmaceutica AG (BPMUF) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of B+, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.
The current technical analysis reveals key indicators including an RSI of 63.45, suggesting the stock is in a neutral condition. Our forecasting models predict significant price movements, with a 12-month target of $59.62.
Key financial metrics showcase the company's fundamental strength, including a P/E ratio of -961.39 and a market capitalization of 752.8M. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.